Epitalon vs FOXO4-DRI: How Do These Peptides Differ?

Structural composition and comparative molecular size

Epitalon is a tetrapeptide (4-amino acid sequence) with the composition Ala-Glu-Asp-Gly. The sequence contains two acidic residues (glutamic acid and aspartic acid), one nonpolar residue (alanine), and one amino acid with a small, polar side chain (glycine). The peptide has a molecular formula of C16H26N4O8 and a molar mass of 419.3 Da (CAS number 307-84-6). This tetrapeptide represents one of the smallest synthetic peptides characterized in the research literature. The short sequence and acidic character contribute to its high aqueous solubility and specific biochemical properties.Review · PMID 40141333In vitro · PMID 29124531

FOXO4-DRI is a substantially longer peptide compared to epitalon, with a sequence and length designed specifically for protein-protein interaction disruption. FOXO4-DRI contains a retro-inverso sequence architecture, meaning the amino acid sequence is reversed and each amino acid is in the D-enantiomeric form (right-handed stereochemistry) rather than the natural L-form (left-handed). This structural design allows the peptide to mimic the binding surface of natural proteins while potentially conferring different properties such as greater resistance to proteolytic degradation and altered cellular uptake.In vitro · PMID 40739602In vitro · PMID 40593617

Biochemical origins and biological contexts

Epitalon was originally identified through compositional analysis of epithalamin, a pineal gland-derived polypeptide extract. The tetrapeptide sequence (AEDG) was isolated and characterized as a component of the natural pineal extract, and synthetic epitalon was subsequently developed to reproduce the properties attributed to the natural source material. Research has examined epitalon's molar mass, amino acid composition, and structural characterization through analytical chemistry methods. The connection to the pineal gland derives from the identification of epitalon within the natural pineal polypeptide complex, though the biological significance of this association remains incompletely defined.Review · PMID 40141333In vitro · PMID 29124531

FOXO4-DRI was rationally designed through structure-based drug design targeting the FOXO4 transcription factor and its interaction with the p53 tumor suppressor protein. The retro-inverso peptide design was developed based on structural characterization of the FOXO4-p53 binding interface determined through nuclear magnetic resonance spectroscopy and other structural biology techniques. FOXO4-DRI was engineered to disrupt the FOXO4-p53 nuclear interaction in senescent cells, leading to apoptosis (programmed cell death) of these cells in in-vitro cell-based systems. The retro-inverso architecture confers distinct properties compared to natural L-amino acid peptides.In vitro · PMID 40739602Review · PMID 42021992In vitro · PMID 40593617

Molecular targets and cellular mechanisms

Epitalon's molecular targets and cellular mechanisms remain incompletely characterized. The peptide has been reported to modulate telomerase activity, melatonin synthesis in pineal gland-derived cell cultures, and various gene expression patterns in cultured cell systems. In-vitro cell-based research has examined epitalon's capacity to influence transcription of specific genes, histone acetylation patterns, and chromatin structure in cultured lymphocytes and other cell lines. The peptide has been documented to affect senescence marker expression (p16 and p21) and telomere length in cultured stem cells and fibroblasts. The exact molecular target or receptor for epitalon, if one exists, has not been definitively established through biochemical or structural studies.Review · PMID 40141333In vitro · PMID 32019204Review · PMID 31808038

FOXO4-DRI has a well-defined molecular target: the FOXO4 transcription factor, specifically its protein-protein interaction with p53. In cultured cell systems, FOXO4-DRI directly binds to FOXO4 and disrupts its complexation with p53, resulting in nuclear export of p53 from senescent cell nuclei. This disruption prevents the p53-FOXO4 complex from activating the p21 gene, which normally maintains senescent cell survival. Consequently, disrupted senescent cells shift toward apoptosis and cell death, measurable through standard in-vitro cell viability assays.In vitro · PMID 40739602In vitro · PMID 40593617

Cellular characterization and in-vitro application

Epitalon has been examined in cultured cell systems measuring multiple endpoints including gene expression (via quantitative PCR), histone modification patterns (via chromatin immunoprecipitation), telomerase activity (via telomerase assays), and cell proliferation (via cell counting or MTT assays). In-vitro cell-based studies characterize the peptide's capacity to modulate cellular behavior through changes in senescence markers (p16, p21), telomere length measurements, and various metabolic readouts. These in-vitro observations document epitalon's cellular interactions in defined laboratory cell culture conditions.Review · PMID 31808038In vitro · PMID 32019204In vitro · PMID 41020860

FOXO4-DRI characterization in cultured cell systems focuses on senescent cell-specific apoptosis induction. In-vitro applications measure FOXO4-DRI capacity to eliminate senescent cells while preserving healthy cells through differential toxicity based on senescence-specific survival mechanisms. Cell-based assays quantify senescent cell death through caspase activation, annexin V binding, and other apoptosis markers. Co-immunoprecipitation assays directly measure FOXO4-p53 complex disruption, and fluorescence microscopy visualizes p53 nuclear export following FOXO4-DRI exposure. These specific in-vitro measurements establish FOXO4-DRI's senolytic mechanism of action through a precisely defined molecular interaction rather than through undefined pleiotropic cellular responses.In vitro · PMID 40739602In vitro · PMID 28340347In vitro · PMID 40593617

Analytical characterization and chemical identity

Epitalon is analytically characterized through standard peptide identification methods including high-performance liquid chromatography (HPLC), mass spectrometry, and amino acid composition analysis. The tetrapeptide's small size allows straightforward HPLC separation and purification. Electrospray ionization mass spectrometry confirms the 419.3 Da molar mass definitively. Amino acid analysis via acid hydrolysis quantifies the four constituent amino acids (alanine, glutamic acid, aspartic acid, and glycine) present in the purified peptide.Review · PMID 40141333

FOXO4-DRI analytical characterization includes mass spectrometry verification of the larger peptide and the D-amino acid stereochemistry. High-resolution mass spectrometry distinguishes between L-amino acid and D-amino acid forms (which may have identical molar masses but different fragmentation patterns). Peptide sequencing via Edman degradation must be interpreted carefully for retro-inverso sequences. Amino acid analysis following acid hydrolysis cannot distinguish D- from L-amino acids, so orthogonal methods such as two-dimensional nuclear magnetic resonance spectroscopy are required to confirm the D-enantiomeric composition and retro-inverso architecture.In vitro · PMID 40739602

The studies at a glance

Comparative characterization of epitalon and FOXO4-DRI peptides

Frequently asked questions